1 doctor weighed in:

Is a 24 month trial of tasigna (nilotinib) the best way to go about treating a cml diagnosis?

1 doctor weighed in
Dr. Raymundo Romero
Internal Medicine - Oncology

In brief: YES

Tasigna (nilotinib) - was initially used as sencond line treatment for CML for patients resistant or intolerant to imatinib.
Now it is indicated for first line treatment in CML in chronic phase. Its not a trial but treatment for cml. And yes you are right, we only have 24 month data to date as first line treatment.

In brief: YES

Tasigna (nilotinib) - was initially used as sencond line treatment for CML for patients resistant or intolerant to imatinib.
Now it is indicated for first line treatment in CML in chronic phase. Its not a trial but treatment for cml. And yes you are right, we only have 24 month data to date as first line treatment.
Dr. Raymundo Romero
Dr. Raymundo Romero
Thank
Get help from a real doctor now
Dr. Vicken Poochikian
Board Certified, Internal Medicine
38 years in practice
2M people helped
Continue
108,000 doctors available
Read more answers from doctors